Medfinder
Back to blog

Updated: February 15, 2026

3,680 people read this article

Progesterone shortage: What providers and prescribers need to know in 2026

Summarize with AI


Overview

A clinical briefing on the 2026 Progesterone shortage: timeline, affected formulations, prescribing implications, and tools for providers.

9%Hard to findin stock right now

Is Progesterone in stock near you?

Based on 99 real pharmacy checks · 10 patients helped

Verified 2h ago

Provider Briefing: The Progesterone Shortage in 2026

The ongoing Progesterone shortage has moved from an intermittent inconvenience to a persistent challenge affecting clinical workflows across OB/GYN, reproductive endocrinology, primary care, and endocrinology. As of early 2026, three distinct Progesterone formulations remain on the ASHP drug shortage database, and the situation requires proactive management from prescribers.

This briefing covers the current state of the shortage, its clinical implications, and practical resources to help you keep your patients on therapy.

Don't wait on hold.
Check live stock now.

Timeline: How We Got Here

Progesterone supply issues are not new, but they've intensified over the past several years:

  • 2011-2019: Intermittent shortages of Progesterone injection, largely driven by increased demand for preterm birth prevention following the FDA approval of Makena (Hydroxyprogesterone Caproate) and subsequent supply gaps.
  • 2023: Progesterone capsule shortages emerged as multiple generic manufacturers experienced production disruptions. The injectable shortage persisted.
  • 2024: Endometrin (vaginal insert) was added to the ASHP shortage list. American Regent exited the Progesterone injection market, further constraining supply.
  • 2025-2026: All three formulations — capsules, injection, and vaginal inserts — remain on shortage. Aurobindo has not provided availability updates. Amneal and Virtus (Prometrium) continue supplying capsules, but intermittent gaps persist. AuroMedics and Hikma supply injection, with variable availability.

Prescribing Implications

The multi-formulation nature of this shortage complicates clinical decision-making in several ways:

Menopausal Hormone Therapy (MHT)

For patients on combination estrogen-Progesterone therapy for endometrial protection, oral micronized Progesterone (Prometrium, 200 mg at bedtime for 12 days per cycle or 100 mg continuous) remains the preferred regimen. When unavailable:

  • Medroxyprogesterone acetate (Provera) 2.5-5 mg daily continuous or 5-10 mg for 12-14 days per cycle is the most established alternative for endometrial protection.
  • Norethindrone acetate (Aygestin) 2.5-5 mg for 12-14 days per cycle is another option.
  • Note that switching from bioidentical Progesterone to a synthetic progestin may concern patients who specifically chose Prometrium for its bioidentical profile. Discuss the evidence on comparative risks and benefits.

Amenorrhea

For progestin withdrawal to induce menses, Medroxyprogesterone 10 mg for 5-10 days is a well-established alternative to Progesterone 400 mg for 10 days.

Fertility and ART

This is where the shortage has the most significant clinical impact. Vaginal Progesterone (Endometrin inserts, Crinone gel) is standard of care for luteal phase support in IVF cycles. Options when commercial vaginal products are unavailable:

  • Compounded vaginal Progesterone suppositories (typically 100-200 mg twice daily) — requires identifying a reliable compounding pharmacy.
  • Intramuscular Progesterone in oil (50-100 mg daily) — effective but also on shortage and associated with injection site pain.
  • Switching between vaginal formulations — if Endometrin inserts are unavailable, Crinone gel (8%, daily or twice daily) may be substitutable, and vice versa.
  • Oral Progesterone is generally not recommended as a substitute for vaginal Progesterone in ART due to lower uterine tissue concentrations and inferior outcomes in some studies.

Preterm Birth Prevention

For patients with a history of spontaneous preterm birth or short cervix, vaginal Progesterone (200 mg suppository or Crinone 8%) is evidence-based. With the FDA's 2023 request for voluntary withdrawal of Makena (17-alpha Hydroxyprogesterone Caproate), vaginal Progesterone has become even more central to preterm birth prevention. Supply constraints in this setting are particularly concerning.

Current Availability Picture

Based on ASHP data and manufacturer communications:

  • Oral capsules: Amneal (generic) and Virtus (Prometrium) — available but with intermittent supply gaps. Aurobindo — status unknown.
  • Injection (50 mg/mL): AuroMedics — available. Hikma — available with constraints. American Regent — no longer marketing. Fresenius Kabi — shortage due to increased demand and manufacturing delays.
  • Vaginal inserts (Endometrin): Listed on shortage. Check with Ferring Pharmaceuticals for current allocation.
  • Vaginal gel (Crinone): Not separately listed on ASHP shortage but may have local availability issues.
48,463+ patients found their medications in stock
48K+
5-star rating

Cost and Access Considerations

Cost varies widely by formulation, which may affect patient adherence and access:

  • Generic oral capsules: ~$14-$30 with coupon (MedFinder, GoodRx, SingleCare); retail ~$79 for 30 capsules. Covered by most plans, Tier 1-2.
  • Prometrium (brand): $200-$422 for 90 capsules without insurance.
  • Crinone 8% gel: $200-$350 per box. May require prior authorization.
  • Endometrin inserts: $300-$600 per cycle. Often covered under fertility benefit or pharmacy benefit with PA.
  • IM Progesterone: $50-$150 per vial.
  • Compounded products: Variable; typically $30-$100 per month. Rarely covered by insurance.

For patients struggling with cost, discount programs and patient assistance are available. Point patients to resources like NeedyMeds, RxAssist, and pharmacy discount cards. A patient-facing guide is available at how to save money on Progesterone.

Tools and Resources for Your Practice

  • Medfinder for Providers: Real-time pharmacy stock lookup for Progesterone and other medications. Helps your team quickly identify where patients can fill prescriptions.
  • ASHP Drug Shortage Database: Monitor shortage status updates for all Progesterone formulations.
  • Compounding pharmacy networks: Establish relationships with 1-2 reliable compounding pharmacies that can prepare Progesterone suppositories or creams when commercial products are unavailable.
  • Prior authorization templates: For practices prescribing brand-name or vaginal formulations, pre-built PA templates can reduce administrative burden.
Skip the calls, skip the stress.
50K+
Medications
Found
99%
Success
Rate
6+
Hours saved
on average

Looking Ahead

The Progesterone shortage is unlikely to resolve overnight. With manufacturer exits, ongoing production challenges, and steadily growing demand, providers should plan for continued intermittent supply disruptions through 2026 and potentially beyond.

Key actions to future-proof your practice:

  1. Establish formulary alternatives for each indication (MHT, amenorrhea, ART, preterm birth prevention)
  2. Build relationships with compounding pharmacies as a backup supply source
  3. Educate patients about the shortage proactively — don't wait for them to discover it at the pharmacy counter
  4. Use tools like Medfinder to streamline the process of finding in-stock pharmacies
  5. Monitor ASHP shortage updates regularly

Final Thoughts

The Progesterone shortage requires a multi-pronged approach from prescribers: awareness of which formulations are affected, familiarity with alternatives for each clinical indication, and practical tools to help patients find available supply. By building shortage contingencies into your clinical workflow now, you can minimize treatment disruptions for your patients.

For a provider-focused guide on helping patients locate Progesterone, see how to help your patients find Progesterone in stock. For patient-facing resources you can share, see our patient shortage update and alternatives guide.

Real-time availability

Is Progesterone in stock near you?

In shortage
9%Hard to findin stock right now

Verified 2h ago

Based on 99 real pharmacy checks · 10 patients helped

Progesterone is in a shortage right now — Medfinder calls pharmacies near you to track down the ones that have it.

As of November 18, 2026, 7:00 AM ET, Progesterone is currently experiencing a shortage. Across 99 pharmacy checks Medfinder placed in the last 30 days, Progesterone was confirmed in stock 9% of the time.

Pharmacy checks
99
FDA status
Not listed
Updated
2h ago

Progesterone is not on the FDA's active shortage list. Medfinder's own pharmacy calls put real-time availability at 9% across 99 checks in the last 30 days. Availability varies by metro, with the most pharmacy activity recorded around Phoenix, AZ. These numbers are recomputed continuously from live pharmacy calls, so this page reflects current conditions rather than a static estimate.

Progesterone availability questions

Is Progesterone in stock right now?

As of November 18, 2026, 7:00 AM ET, Progesterone was confirmed in stock at 9% of 99 pharmacies Medfinder checked in the last 30 days. Availability changes daily, so we re-check in real time when you search.

How does Medfinder help me find Progesterone?

Medfinder calls pharmacies in your area to verify whether Progesterone and your specific dose are in stock, then sends you the pharmacy name, address, and phone number.

Need Progesterone? We'll find the pharmacy that has it.

Sources: FDA Drug Shortages + Medfinder pharmacy data · Methodology · Full Progesterone data

Frequently Asked Questions

As of early 2026, ASHP lists Progesterone capsules, Progesterone injection (in oil), and Progesterone vaginal inserts (Endometrin) on the drug shortage database. Vaginal gel (Crinone) is not separately listed but may have local availability issues.

Oral Progesterone is generally not recommended as a substitute for vaginal Progesterone in ART/IVF due to lower uterine tissue concentrations and potentially inferior outcomes. Compounded vaginal suppositories or intramuscular Progesterone in oil are more appropriate alternatives when commercial vaginal products are unavailable.

Medroxyprogesterone acetate (Provera) 2.5-5 mg daily continuous or 5-10 mg for 12-14 days per cycle is the most established alternative for endometrial protection during estrogen therapy. Norethindrone acetate (Aygestin) is another option. Both are widely available and inexpensive.

Use Medfinder for Providers (medfinder.com/providers) to check real-time pharmacy stock. Recommend independent and specialty pharmacies, establish relationships with compounding pharmacies, and consider prescribing alternative formulations when appropriate. Proactively educate patients about the shortage.

How do I find Progesterone in stock near me?
Medfinder checks real pharmacy inventory and finds the pharmacies that have it.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Progesterone also looked for:

48,463 have already found their meds with Medfinder.

Start your search today.

48K+
5-star ratingTrusted by 48,463 Happy PatientsRead our reviews on Trustpilot →
      What med are you looking for?
⊙  Find Your Meds

Your information is private and never shared.

99% success rate
Fast turnaround time
Never call another pharmacy

Find Progesterone in stock